A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma

Sorafenib, a multikinase inhibitor, is the first and only drug, which improves significantly the overall survival in patients with advanced hepatocellular carcinoma (HCC). However, many patients experience diverse side effects, some of them severe and unexpected. To date, acute acalculous cholecysti...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Aihara, Yosuke, Yoshiji, Hitoshi, Yamazaki, Masaharu, Ikenaka, Yasuhide, Noguchi, Ryuichi, Morioka, Chie, Kaji, Kosuke, Tastumi, Haruki, Nakanishi, Keisuke, Nakamura, Maiko, Yamao, Junichi, Toyohara, Masahisa, Mitoro, Akira, Sawai, Masayoshi, Yoshida, Motoyuki, Fujimoto, Masao, Uemura, Masahito, Fukui, Hiroshi
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Co., Limited 2012
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360105/
https://ncbi.nlm.nih.gov/pubmed/22645635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v4.i5.115
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky